Sun, Jan 25, 2015, 4:35 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Cytokinetics, Incorporated Message Board

  • dctrig dctrig Mar 13, 2013 1:32 PM Flag

    Ask Yourself Why CYTK Stays Above $1

    Most small companies hovering near $1 are mercilessly attacked and many stay below $1; CYTK appears to be different. Too many closely linked meetings in a 10-day period: 1) Amgen and Cytokinetics in San Francisco for Cardiology meeting, 3/9-11; 2) Cytokinetics in San Diego for neurology meeting and Biogen Idec also there, 3/16-23; 3) CYTK to give corporate UDATE on 3/18 in Laguna Niguel, 90 minutes from S.D.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Market manipulators can't push this stock below $1

    • Notice that Zacks has a strong buy on CYTK and a strong sell on SPPI. The downside risk of CYTK is less than T-bills. Smart buyers will risk losing 20% on CYTK vs. making 500%.

    • I used to ask myself why CYTK stayed below $2, but biotech, I found, is a different kind of a ride.

      Nobody really cares about quarterly reports unless they're running out of money or shutting down the pipeline.

      You buy the best one you can find for your buck, and you follow closely.

      I think more and more little guys are taking notice, and a couple of the big ones are loading up.

      This will be a great place to be when some good news pops, and I think that date is getting closer and closer.

      • 1 Reply to marketman9876
      • Marketman: I agree that the data continues to mature. Newbies need to understand that every time Amgen moves Mecarbil into the next pahse of a trial, it has undergone rigorous vetting. Contrast that with joke CTIC that has never met a trial it didn't like and wasted over $1B. LOL, the Bianco brothers have scooped up tens of millions in compensation-but hey, they did give up their corporate jet some years back!

7.38+0.33(+4.68%)Jan 23 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.